Michael Bornstein
Pediatrics · Richmond, TXNPI 1225024326
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.7% of the total across 254 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 30 manufacturers reported payments, led by Corium, LLC at 27.2% of the total. Among pediatrics clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 254 payments — averaging $20.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Corium, LLC$1K
- Supernus Pharmaceuticals, Inc.$797
- GSK$397
- Ironshore Pharmaceuticals Inc.$346
- Cumberland Pharmaceuticals, Inc.$240
- Pfizer$227
- plus $2K from 24 others
Across 355 payments — averaging $3167.30 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- GSK$549K
- Sanofi Pasteur Inc.$222K
- Modernatx, Inc.$171K
- Novavax Inc$94K
- Sanofi US Services Inc.$68K
- Takeda Pharmaceuticals U.S.A., Inc.$20K
What the payments were for
- Food & beverage$4,97298%
- Other$1192%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Corium, LLC | 75 | $1,384 |
| Supernus Pharmaceuticals, Inc. | 35 | $797 |
| GSK | 19 | $397 |
| Ironshore Pharmaceuticals Inc. | 12 | $346 |
| Cumberland Pharmaceuticals, Inc. | 16 | $240 |
| Pfizer | 10 | $227 |
| Tris Pharma Inc | 10 | $218 |
| Merck | 14 | $193 |
| UCB, Inc. | 5 | $164 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $146 |
| Baxter Healthcare | 1 | $119 |
| Sanofi Pasteur Inc. | 7 | $118 |
| Cranial Technologies, Inc | 7 | $107 |
| Neos Therapeutics, LP | 7 | $103 |
| Genentech USA, Inc. | 4 | $71 |
| Shire North American Group Inc | 3 | $57 |
| Sanofi-aventis U.S. LLC | 2 | $55 |
| Medtronic | 1 | $53 |
| Collegium Pharmaceutical, Inc. | 3 | $52 |
| Verrica Pharmaceuticals Inc. | 3 | $45 |
| Biomarin Pharmaceutical Inc. | 2 | $32 |
| Novartis | 2 | $32 |
| AstraZeneca | 1 | $23 |
| Tactile Systems Technology Inc | 1 | $20 |
| Azurity Pharmaceuticals, Inc. | 1 | $20 |
| Seqirus USA Inc | 1 | $16 |
| Nestle Healthcare Nutrition Inc. | 1 | $16 |
| Biogen | 1 | $14 |
| Aquestive Therapeutics, Inc. | 1 | $14 |
| Phadia US Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Azstarys$319
- QELBREE$250
- JORNAY PM$209
- Hillrom - Spot Vision Screener$119
- BEXSERO$110
How this compares
$5,091 in reported general payments places this provider in the 95th percentile of 5,361 pediatrics providers in Texas.
Other pediatrics in Richmond
- Pedro PiedraHouston$729K
- Jason RiehsFrisco$216K
- Ivonne Sahagun-CarreonNew Braunfels$168K
- Angela ScheuerleDallas$118K
- Dianna BurnsSan Antonio$100K
- Jason TerkKeller$93K
- Vernon SuttonHouston$90K
- Laura ScalfanoPlano$74K
- Patricia AmersonSan Antonio$73K
- Ralph DeberardinisDallas$56K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.